How we’re beating the HRT shortage
“Pharmaceutical companies say that they have struggled to keep up with the high demand for product,” says Harris, “meaning that stock has been low for some time…
Glaxo boss clears path for sale of consumer business
Sales of its shingles vaccine, Shingrix, fell as health services focused on the rollout of the Covid jab. In the final quarter of 2021, GSK said it…
We took bribes to save money for the NHS, accused officials say
Jerram, who was the head of medicines management at the IoW CCG at the time of the investigation, told undercover reporters that he had recently attended a…
Jeff Bezos wants to live forever and GSK can’t compete
Dame Emma has been under intense pressure to transform GSK’s prospects and Barron was at the very heart of her strategy and her defence against attempts by…
Sensyne Health shares collapse on emergency fundraising
The Oxford-based company uses artificial intelligence to analyse anonymised patient data and discover new medicines. It has a deal to use about 22.5m medical records. JP Morgan…
Inside the hunt for a Covid ‘super vaccine’
Clive Dix, former chair of the UK’s vaccine taskforce, agrees, arguing that companies have been claiming they could develop such a vaccine for flu “since I was…
First plant-based Covid vaccine moves a step closer
GlaxoSmithKline is seeking approval for the world’s first plant-based vaccine as it scrambles to catch up with rivals in the race to treat the new variants of…
AstraZeneca lost the vaccine battle in Europe and the US – but is now winning the war globally
But despite the company’s early success in producing a workable Covid vaccine, helping the UK to steal a march on the rest of Europe in vaccinating against…